Cited by 16Neurological Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 289 of the 289 references it cites were found in a registry or an index.

Mouse models of neurodegenerative disease: preclinical imaging and neurovascular component

Albanese, Sandra, Greco, Adelaide, Auletta, Luigi, Mancini, Marcello·2018·Brain Imaging and Behavior

DOI 10.1007/s11682-017-9770-3

Open this paper in CoChat — free account

Abstract

Neurodegenerative diseases represent great challenges for basic science and clinical medicine because of their prevalence, pathologies, lack of mechanism-based treatments, and impacts on individuals. Translational research might contribute to the study of neurodegenerative diseases. The mouse has become a key model for studying disease mechanisms that might recapitulate in part some aspects of the corresponding human diseases. Neurodegenerative disorders are very complicated and multifactorial. This has to be taken in account when testing drugs. Most of the drugs screening in mice are very difficult to be interpretated and often useless. Mouse models could be condiderated a 'pathway models', rather than as models for the whole complicated construct that makes a human disease. Non-invasive in vivo imaging in mice has gained increasing interest in preclinical research in the last years thanks to the availability of high-resolution single-photon emission computed tomography (SPECT), positron emission tomography (PET), high field Magnetic resonance, Optical Imaging scanners and of highly specific contrast agents. Behavioral test are useful tool to characterize different animal models of neurodegenerative pathology. Furthermore, many authors have observed vascular pathological features associated to the different neurodegenerative disorders. Aim of this review is to focus on the different existing animal models of neurodegenerative disorders, describe behavioral tests and preclini…

Integrity signals

Registry

Crossref · 10.1007/s11682-017-9770-3

Cites

289 of 289 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
Applications of the Morris water maze in the study of learning and memory
D’Hooge, R., & Deyn, P. P. D. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00067-4 · Cited by 2,083
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer’s Disease
Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.-H., Haass, C., Staufenbiel, M., Konnerth, A., & Garaschuk, O. (2008) · Science · doi:10.1126/science.1162844 · Cited by 1,125
Cerebral amyloid angiopathy. A critical review.
Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,070
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J., Storey, E., Srivastava, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,026
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
The genetic landscape of Alzheimer disease: clinical implications and perspectives
Van Cauwenberghe, C., Van Broeckhoven, C., & Sleegers, K. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.117 · Cited by 863
Alzheimer disease and cerebrovascular pathology: an update
Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200068 · Cited by 680
Animal models of Parkinson's disease
Betarbet, R. S., Sherer, T., & Greenamyre, J. T. (2002) · BioEssays · doi:10.1002/bies.10067 · Cited by 617
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
Azzouz, M., Ralph, G. S., Storkebaum, E., Walmsley, L. E., Mitrophanous, K. A., Kingsman, S. M., Carmeliet, P., & Mazarakis, N. D. (2004) · Nature · doi:10.1038/nature02544 · Cited by 588
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
Zhao, Y., & Adjei, A. A. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0465 · Cited by 573
Drug Design, Development and Therapy
(2020) · Drug Design Development and Therapy · doi:10.2147/dddt · Cited by 566
Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets
Klein, W. L. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00050-5 · Cited by 551
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection
Storkebaum, E., Lambrechts, D., & Carmeliet, P. (2004) · BioEssays · doi:10.1002/bies.20092 · Cited by 508
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein
Fleming, S. M., Salcedo, J. D., Fernagut, P., Rockenstein, E. M., Masliah, E., Levine, M. S., & Chesselet, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3080-04.2004 · Cited by 477
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration
Zhong, Z., Deane, R., Ali, Z., Parisi, M., Shapovalov, Y., O'Banion, M. K., Stojanovic, K., Sagare, A., Boillee, S., Cleveland, D. W., et al. (2008) · Nature Neuroscience · doi:10.1038/nn2073 · Cited by 476
A delicate balance: Iron metabolism and diseases of the brain
Hare, D. J., Ayton, S., Bush, A. I., & Lei, P. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00034 · Cited by 459
Animal models of Parkinson’s disease
Blandini, F., & Armentero, M. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08491.x · Cited by 428
Spatial navigational strategies correlate with gray matter in the hippocampus of healthy older adults tested in a virtual maze
Konishi, K., & Bohbot, V. D. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00001 · Cited by 426
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory‐Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 425
Experimental Autoimmune Encephalomyelitis in the Mouse
Miller, S. D., & Karpus, W. J. (2007) · Current Protocols in Immunology · doi:10.1002/0471142735.im1501s77 · Cited by 404
Animal models of Multiple Sclerosis
Procaccini, C., Rosa, V. D., Pucino, V., Formisano, L., & Matarese, G. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.042 · Cited by 403
Assessment of Motor Balance and Coordination in Mice using the Balance Beam
Luong, T. N., Carlisle, H. J., Southwell, A. L., & Patterson, P. H. (2011) · Journal of Visualized Experiments · doi:10.3791/2376 · Cited by 401
Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathy
Hawkes, C. A., & McLaurin, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805453106 · Cited by 397
Transgenic mouse models of Alzheimer’s disease.
Elder, G. A., Gama Sosa, M. A., & De Gasperi, R. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20159 · Cited by 336
Mouse models of Alzheimer's disease
Hall, A. M., & Roberson, E. D. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.017 · Cited by 317
Cognitive Dysfunction Precedes Neuropathology and Motor Abnormalities in the YAC128 Mouse Model of Huntington's Disease
Raamsdonk, J. M. V., Pearson, J., Slow, E., Hossain, S. M., Leavitt, B. R., & Hayden, M. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0590-05.2005 · Cited by 315
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis
Vercelli, A., Mereuta, O., Garbossa, D., Muraca, G., Mareschi, K., Rustichelli, D., Ferrero, I., Mazzini, L., Madon, E., & Fagioli, F. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.016 · Cited by 310
Theiler's Virus Infection: a Model for Multiple Sclerosis
Oleszak, E. L., Chang, J. R., Friedman, H. P., Katsetos, C. D., & Platsoucas, C. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.174-207.2004 · Cited by 307
PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302
Age‐dependent cognitive decline in the APP23 model precedes amyloid deposition
Dam, D. V., D’Hooge, R., Staufenbiel, M., Ginneken, C. J. V., Meir, F. V., & Deyn, P. P. D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02444.x · Cited by 300
Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI)
Cheng, K. K., Chan, P. S., Fan, S., Kwan, S. M., Yeung, K. L., Wáng, Y. X. J., Chow, A. H. L., Wu, E. X., & Baum, L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.005 · Cited by 300
Cerebrovascular and blood–brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology
Drouin‐Ouellet, J., Sawiak, S. J., Cisbani, G., Lagacé, M., Kuan, W., Saint‐Pierre, M., Dury, R. J., Alata, W., St‐Amour, I., Mason, S. L., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24406 · Cited by 288
Alzheimer Disease in a Mouse Model: MR Imaging–guided Focused Ultrasound Targeted to the Hippocampus Opens the Blood-Brain Barrier and Improves Pathologic Abnormalities and Behavior
Burgess, A., Dubey, S., Yeung, S., Hough, O., Eterman, N., Aubert, I., & Hynynen, K. (2014) · Radiology · doi:10.1148/radiol.14140245 · Cited by 286
Molecular SPECT Imaging: An Overview
Khalil, M. M., Tremoleda, J. L., Bayomy, T., & Gsell, W. (2011) · International Journal of Molecular Imaging · doi:10.1155/2011/796025 · Cited by 276
Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity
Taylor, T. N., Caudle, W. M., Shepherd, K. R., Noorian, A. R., Jackson, C. R., Iuvone, P. M., Weinshenker, D., Greene, J. G., & Miller, G. W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1495-09.2009 · Cited by 275
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation
Ryu, J. K., Petersen, M. A., Murray, S. G., Baeten, K. M., Meyer-Franke, A., Chan, J. P., Vagena, E., Bedard, C., Machado, M. R., Coronado, P. E. R., et al. (2015) · Nature Communications · doi:10.1038/ncomms9164 · Cited by 271
Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice
Chen, L., Cagniard, B., Mathews, T. A., Jones, S. R., Koh, H. C., Ding, Y., Carvey, P. M., Ling, Z., Kang, U. J., & Zhuang, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413955200 · Cited by 268
Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice
Knobloch, M., Konietzko, U., Krebs, D. C., & Nitsch, R. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.019 · Cited by 259
Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid
Giménez‐Llort, L., Blázquez, G., Cañete, T., Johansson, B. A., Oddo, S., Tobeña, A., LaFerla, F. M., & Fernández‐Teruel, A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.007 · Cited by 246
Noninvasive Molecular Imaging of Neuroinflammation
Jacobs, A. H., Tavitian, B., & the INMiND consortium (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.53 · Cited by 245
Animal Models of Huntington's Disease
Ramaswamy, S., McBride, J. L., & Kordower, J. H. (2007) · ILAR Journal · doi:10.1093/ilar.48.4.356 · Cited by 240
The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis
Zamboni, P. (2006) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.99.11.589 · Cited by 239
Prominent Cerebral Amyloid Angiopathy in Transgenic Mice Overexpressing the London Mutant of Human APP in Neurons
Dorpe, J. V., Smeijers, L., Dewachter, I., Nuyens, D., Spittaels, K., den Haute, C. V., Mercken, M. H., Moechars, D., Laenen, I., Kuipéri, C., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64644-5 · Cited by 223
Early formation of mature amyloid‐β protein deposits in a mutant APP transgenic model depends on levels of Aβ1–42
Rockenstein, E. M., Mallory, M. E., Mante, M., Sisk, A., & Masliaha, E. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1247 · Cited by 221
Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease
Yasuhara, T., Shingo, T., Kobayashi, K., Takeuchi, A., Yano, A., Muraoka, K., Matsui, T., Miyoshi, Y., Hamada, H., & Date, I. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03254.x · Cited by 216
Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging
Poduslo, J. F., Wengenack, T. M., Curran, G. L., Wısnıewskı, T., Sigurdsson, E. M., Macura, S. I., Borowski, B., & Jack, C. R. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0550 · Cited by 216
ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ 1–40 Peptides
Xiong, H., Callaghan, D., Jones, A., Bai, J., Rasquinha, I., Smith, C., Pei, K., Walker, D. G., Lue, L., Stanimirovic, D. B., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5103-08.2009 · Cited by 214
Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl‐ 11 C]‐2‐(4′‐methylaminophenyl)‐ 6‐hydroxybenzothiazole
Stankoff, B., Freeman, L. A., Aigrot, M., Chardain, A., Dollé, F., Williams, A., Galanaud, D., Armand, L., Lehéricy, S., Lubetzki, C., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22320 · Cited by 214
Behavioral phenotyping of mouse models of Parkinson's disease
Taylor, T. N., Greene, J. G., & Miller, G. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.004 · Cited by 212
Alpha-synuclein and transgenic mouse models
Fernagut, P., & Chesselet, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.001 · Cited by 210
Olfactory deficits in mice overexpressing human wildtype α‐synuclein
Fleming, S. M., Tetreault, N. A., Mulligan, C. K., Hutson, C. B., Masliah, E., & Chesselet, M. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06346.x · Cited by 209
Mouse Models of Multiple Sclerosis: Experimental Autoimmune Encephalomyelitis and Theiler’s Virus-Induced Demyelinating Disease
McCarthy, D. P., Richards, M. H., & Miller, S. D. (2012) · Methods in molecular biology · doi:10.1007/978-1-60761-720-4_19 · Cited by 209
Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis
Redwine, J. M., Kosofsky, B. E., Jacobs, R. E., Games, D., Reilly, J. F., Morrison, J. H., Young, W. G., & Bloom, F. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242746599 · Cited by 204
Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α‐synuclein over‐expression
Fernagut, P., Hutson, C. B., Fleming, S. M., Tetreaut, N. A., Salcedo, J. D., Masliah, E., & Chesselet, M.-F. (2007) · Synapse · doi:10.1002/syn.20456 · Cited by 202
Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis
Miyazaki, K., Ohta, Y., Nagai, M., Morimoto, N., Kurata, T., Takehisa, Y., Ikeda, Y., Matsuura, T., & Abe, K. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22594 · Cited by 197
Modeling PD pathogenesis in mice: Advantages of a chronic MPTP protocol
Meredith, G. E., Totterdell, S., Potashkin, J. A., & Surmeier, D. J. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.012 · Cited by 193
The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease
Joglar, B., Rodríguez‐Pallares, J., Rodriguez-Perez, A. I., Rey, P., Guerra, M. J., & Labandeira-García, J. L. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05999.x · Cited by 188
Dense-Core Plaques in Tg2576 and PSAPP Mouse Models of Alzheimer's Disease Are Centered on Vessel Walls
Kumar‐Singh, S., Pirici, D. N., McGowan, E. M., Serneels, S., Ceuterick, C., Hardy, J., Duff, K., Dickson, D. W., & Broeckhoven, C. V. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62995-1 · Cited by 180
A New Mouse Mutant with Progressive Motor Neuronopathy
Schmalbruch, H., Jensen, H. S., Bjærg, M., Kamieniecka, Z., & Kurland, L. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199105000-00002 · Cited by 180
Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis
Kirkinezos, I. G., Hernandez, D., Bradley, W. G., & Moraes, C. T. (2003) · Annals of Neurology · doi:10.1002/ana.10597 · Cited by 179
Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model
Reilly, J. F., Games, D., Rydel, R. E., Freedman, S. B., Schenk, D., Young, W. G., Morrison, J. H., & Bloom, F. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0330745100 · Cited by 175
Parkinson’s disease: genetic versus toxin‐induced rodent models
Terzioglu, M., & Galter, D. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06302.x · Cited by 173
Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra
Faull, R. L. M., & Laverty, R. (1969) · Experimental Neurology · doi:10.1016/0014-4886(69)90081-8 · Cited by 172
Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice
Starkey, M. L., Barritt, A. W., Yip, P. K., Davies, M., Hamers, F. P. T., McMahon, S. B., & Bradbury, E. J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.06.017 · Cited by 170
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Fleming, S. M., Ekhator, O. R., & Ghisays, V. (2013) · Journal of Visualized Experiments · doi:10.3791/50303 · Cited by 169
Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease
Luchtman, D. W., Shao, D., & Song, C. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.04.021 · Cited by 167
Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis
LIEBETANZ, D., & MERKLER, D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.032 · Cited by 166
Longitudinal Evaluation of theHdh(CAG)150Knock-In Murine Model of Huntington's Disease
Heng, M. Y., Tallaksen‐Greene, S. J., Detloff, P. J., & Albin, R. L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1830-07.2007 · Cited by 165
Automated deformation analysis in the YAC128 Huntington disease mouse model
Lerch, J. P., Carroll, J. B., Spring, S., Bertram, L. N., Schwab, C., Hayden, M. R., & Henkelman, R. M. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.08.033 · Cited by 164
A partial lesion model of Parkinson's disease in mice – Characterization of a 6-OHDA-induced medial forebrain bundle lesion
Boix, J., Padel, T., & Paul, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.053 · Cited by 162
Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation
Fernagut, P., Diguet, E., Stefanova, N., Biran, M., Wenning, G. K., Canioni, P., Bioulac, B. H., & Tison, F. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00205-1 · Cited by 159
Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer’s disease
Dorr, A. E., Sahota, B., Chinta, L. V., Brown, M. E., Lai, A. Y., Ma, K., Hawkes, C. A., McLaurin, J., & Stefanovic, B. (2012) · Brain · doi:10.1093/brain/aws243 · Cited by 156
A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions
Bonito-Oliva, A., Masini, D., & Fisone, G. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00290 · Cited by 155
Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
Webster, S. J., Bachstetter, A. D., & Eldik, L. J. V. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt182 · Cited by 153
Rodent genetic models of Huntington disease
Heng, M. Y., Detloff, P. J., & Albin, R. L. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.005 · Cited by 152
Age-Dependent Cerebrovascular Abnormalities and Blood Flow Disturbances in APP23 Mice Modeling Alzheimer's Disease
Beckmann, N., Schuler, A., Mueggler, T., Meyer, E. P., Wiederhold, K., Staufenbiel, M., & Krucker, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08453.2003 · Cited by 149
Characterization of relapsing–remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice
Berard, J. L., Wolak, K., Fournier, S., & David, S. (2010) · Glia · doi:10.1002/glia.20935 · Cited by 147
Novel Object Recognition as a Facile Behavior Test for Evaluating Drug Effects in AβPP/PS1 Alzheimer's Disease Mouse Model
Zhang, R., Xue, G., Wang, S., Zhang, L., Shi, C., & Xie, X. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120151 · Cited by 146
PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
Venneti, S., Lopresti, B. J., Wang, G., Hamilton, R. L., Mathis, C. A., Klunk, W. E., Apte, U. M., & Wiley, C. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.005 · Cited by 138
Novel Role for Vascular Endothelial Growth Factor (VEGF) Receptor-1 and Its Ligand VEGF-B in Motor Neuron Degeneration
Poesen, K., Lambrechts, D., Damme, P. V., Dhondt, J., Bender, F. L. P., Frank, N., Bogaert, E., Claes, B., Heylen, L., Verheyen, A., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1092-08.2008 · Cited by 137
Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease
Hickey, M. A., Zhu, C., Medvedeva, V. P., Lerner, R. P., Patassini, S., Franich, N. R., Maiti, P., Frautschy, S. A., Zeitlin, S. O., Levine, M. S., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-12 · Cited by 135
Spines, plasticity, and cognition in Alzheimer's model mice
Spires-Jones, T., & Knafo, S. (2012) · Neural Plasticity · doi:10.1155/2012/319836 · Cited by 133
Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease
Franciosi, S., Ryu, J. K., Shim, Y. A., Hill, A. M., Connolly, C., Hayden, M. R., McLarnon, J. G., & Leavitt, B. R. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.003 · Cited by 131
Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice
Bellucci, A., Luccarini, I., Scali, C., Prosperi, C., Giovannini, M. G., Pepeu, G., & Casamenti, F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.03.012 · Cited by 131
Altered cognitive-emotional behavior in early experimental autoimmune encephalitis – Cytokine and hormonal correlates
Acharjee, S., Nayani, N., Tsutsui, M., Hill, M. N., Ousman, S. S., & Pittman, Q. J. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.07.003 · Cited by 129
Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease
Poisnel, G., Hérard, A., Tayara, N. E. T. E., Bourrin, E., Volk, A., Kober, F., Delatour, B., Delzescaux, T., Debeir, T., Rooney, T., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.026 · Cited by 123
Behavioral Phenotyping of Parkin-Deficient Mice: Looking for Early Preclinical Features of Parkinson's Disease
Rial, D., de Castro, A. A., Machado, N. J., Garção, P., Gonçalves, F. Q., Silva, H. B. L., Tomé, Â. R., Köfalvi, A., Corti, O., Raisman‐Vozari, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114216 · Cited by 122
Small-Animal PET Imaging of Amyloid-Beta Plaques with [11C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease
Manook, A., Yousefi, B. H., Willuweit, A., Platzer, S., Reder, S., Voß, A., Huisman, M. C., Settles, M., Neff, F., Velden, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031310 · Cited by 121
A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis.
Lowry, K., Murray, S. S., McLean, C., Talman, P. S., Mathers, S., Lopes, E., & Cheema, S. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201753275463 · Cited by 120
Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer’s disease
Girard, S. D., Jacquet, M., Baranger, K., Migliorati, M., Escoffier, G., Bernard, A., Khrestchatisky, M., Féron, F., Rivera, S., Roman, F. S., et al. (2014) · Hippocampus · doi:10.1002/hipo.22267 · Cited by 119
Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice
Choi, C., Lee, Y., Gwag, B. J., Cho, S. I., Kim, S., & Suh‐Kim, H. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.10.024 · Cited by 119
Substitute of animals in drug research: An approach towards fulfillment of 4R′s
Sharma, K., Arora, T., Joshi, V., Rathor, N., Mehta, A. K., Mehta, K., & Mediratta, P. K. (2011) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.89750 · Cited by 118
Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor protein
Apelt, J., Kumar, A., & Schliebs, R. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03262-6 · Cited by 117
Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex
Diorio, D. L., Welner, S. A., Butterworth, R. F., Meaney, M. J., & Suranyi-Cadotte, B. E. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90106-t · Cited by 114
Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer’s Disease Transgenic Mice Using Magnetic Resonance Microimaging
Wadghiri, Y. Z., Li, J., Wang, J., Hoang, D. M., Sun, Y., Xu, H., Tsui, W., Li, Y., Boutajangout, A., Wang, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057097 · Cited by 114
Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse
Gorton, L. M., Vuckovic, M. G., Vertelkina, N., Petzinger, G. M., Jakowec, M. W., & Wood, R. I. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.009 · Cited by 112
A touch screen-automated cognitive test battery reveals impaired attention, memory abnormalities, and increased response inhibition in the TgCRND8 mouse model of Alzheimer's disease
Romberg, C., Horner, A. E., Bussey, T. J., & Saksida, L. M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.006 · Cited by 111
The wobbler mouse, an ALS animal model
Moser, J., Bigini, P., & Schmitt‐John, T. (2013) · Molecular Genetics and Genomics · doi:10.1007/s00438-013-0741-0 · Cited by 108
Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models
Nicholson, R. M., Kusne, Y., Nowak, L. A., LaFerla, F. M., Reiman, E. M., & Valla, J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.084 · Cited by 107
Behavioral Disturbances without Amyloid Deposits in Mice Overexpressing Human Amyloid Precursor Protein with Flemish (A692G) or Dutch (E693Q) Mutation
Kumar‐Singh, S., Dewachter, I., Moechars, D., Lübke, U., Jonghe, C. D., Ceuterick, C., Checler, F., Naidu, A., Cordell, B., Cras, P. P., et al. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0272 · Cited by 106
MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease
Helpern, J. A., Lee, P., Falangola, M. F., Dyakin, V. V., Bogart, A., Ardekani, B. A., Duff, K., Branch, C. A., Wısnıewskı, T., de Leon, M. J., et al. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20038 · Cited by 106
Angiogenesis induced by CNS inflammation promotes neuronal remodeling through vessel-derived prostacyclin
Muramatsu, R., Takahashi, C., Miyake, S., Fujimura, H., Mochizuki, H., & Yamashita, T. (2012) · Nature Medicine · doi:10.1038/nm.2943 · Cited by 104
Development of a Smart Nano-vehicle to Target Cerebrovascular Amyloid Deposits and Brain Parenchymal Plaques Observed in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Agyare, E. K., Curran, G. L., Ramakrishnan, M., Yu, C. C., Poduslo, J. F., & Kandimalla, K. K. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9688-y · Cited by 104
Animal models of amyloid‐β‐related pathologies in Alzheimer’s disease
Philipson, O., Lord, A., Gumucio, A., O'Callaghan, P. W., Lannfelt, L., & Nilsson, L. N. G. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07564.x · Cited by 101
Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease
Beauquis, J., Vinuesa, Á., Pomilio, C. J., Pavía, P., Galván, V., & Saravia, F. (2013) · Hippocampus · doi:10.1002/hipo.22219 · Cited by 101
Antisense peptide nucleic acid‐mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice
Turner, B. J., Cheah, I. K.-M., Macfarlane, K. J., Lopes, E. C., Petratos, S., Langford, S. J., & Cheema, S. S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02053.x · Cited by 100
Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS)
Knippenberg, S., Thau, N., Dengler, R., & Petri, S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.04.042 · Cited by 100
Aberrant astrocytes impair vascular reactivity in Huntington disease
Hsiao, H., Chen, Y., Huang, C., Chen, C., Hsu, Y., Chen, H., Chiu, F., Kuo, H., Chang, C., & Chern, Y. (2015) · Annals of Neurology · doi:10.1002/ana.24428 · Cited by 99
Neurovascular abnormalities in humans and mice with Huntington's disease
Lin, C.-Y., Hsu, Y.-H., Lin, M.-H., Yang, T.-H., Chen, H.-M., Chen, Y.-C., Hsiao, H.-Y., Chen, C.-C., Chern, Y., & Chang, C. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.08.019 · Cited by 98
Expression of Vascular Endothelial Growth Factor and Its Receptors in the Central Nervous System in Amyotrophic Lateral Sclerosis
Brockington, A., Wharton, S. B., Fernando, M. S., Gelsthorpe, C., Baxter, L., Ince, P. G., Lewis, C. E., & Shaw, P. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000196134.51217.74 · Cited by 97
Live imaging of amyotrophic lateral sclerosis pathogenesis: Disease onset is characterized by marked induction of GFAP in Schwann cells
Keller, A. F., Gravel, M., & Križ, J. (2008) · Glia · doi:10.1002/glia.20836 · Cited by 95
Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images
Zhang, J., Peng, Q., Li, Q., Jahanshad, N., Hou, Z., Jiang, M., Masuda, N., Langbehn, D. R., Miller, M. I., Mori, S., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.10.027 · Cited by 94
VEGF and angiogenesis in acute and chronic MOG(35–55) peptide induced EAE
Roscoe, W. A., Welsh, M. E., Carter, D. E., & Karlik, S. J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.009 · Cited by 94
Inflammation modulates anxiety in an animal model of multiple sclerosis
Peruga, I., Hartwig, S., Thöne, J., Hovemann, B. T., Gold, R., Juckel, G., & Linker, R. A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.018 · Cited by 93
Genetic Mouse Models of Huntington’s Disease: Focus on Electrophysiological Mechanisms
Cepeda, C., Cummings, D. M., André, V., Holley, S. M., & Levine, M. S. (2010) · ASN NEURO · doi:10.1042/an20090058 · Cited by 92
Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?
Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 91
Chronic and progressive Parkinson's disease MPTP model in adult and aged mice
Muñoz‐Manchado, A. B., Villadiego, J., Romo‐Madero, S., Suárez‐Luna, N., Bermejo‐Navas, A., Rodríguez‐Gómez, J. A., Garrido‐Gil, P., Labandeira-García, J. L., Echevarrı́a, M., López‐Barneo, J., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13409 · Cited by 91
Degeneration of corticospinal and bulbospinal systems in the superoxide dismutase 1G93A G1H transgenic mouse model of familial amyotrophic lateral sclerosis
Zang, D., & Cheema, S. S. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00944-8 · Cited by 90
Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease
Luo, F. R., Rustay, N. R., Ebert, U., Hradil, V. P., Cole, T. B., Llano, D. A., Mudd, S. R., Zhang, Y., Fox, G. B., & Day, M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.005 · Cited by 89
In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography
Rojas, S., Herance, J. R., Gispert, J. D., Abad, S., Llongarriu, È. T., Jiménez, X., Pareto, D., Perpiñá, U., Sarroca, S., Rodrı́guez, E., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.027 · Cited by 88
Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis
Radu, C. G., Shu, C. J., Shelly, S. M., Phelps, M. E., & Witte, O. N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610544104 · Cited by 87
In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease
Pépin, J., Francelle, L., Sauvage, M.-A. C.-D., de Longprez, L., Gipchtein, P., Cambon, K., Valette, J., Brouillet, E., & Flament, J. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.06.023 · Cited by 87
Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow
Li, H., Guo, Q., Inoue, T., Polito, V. A., Tabuchi, K., Hammer, R. E., Pautler, R. G., Taffet, G. E., & Zheng, H. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-28 · Cited by 86
Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
Klohs, J., Rudin, M., Shimshek, D. R., & Beckmann, N. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00032 · Cited by 82
Behavioral Characterization of Quinolinate-Induced Lesions of the Medial Striatum: Relevance for Huntington's Disease
Furtado, J., & Mazurek, M. F. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0054 · Cited by 82
Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis
Oliván, S., Calvo, A. C., Rando, A., Muñoz, M. J., Zaragoza, P., & Osta, R. (2014) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.14-0077 · Cited by 80
Microglial Activation Induced by Neurodegeneration
Zhou, Y. F., Wang, Y., Kovacs, M., Jin, J., & Zhang, J. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500114-mcp200 · Cited by 79
VCAM‐1‐targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis
Serres, S., Mardiguian, S., Campbell, S. J., McAteer, M. A., Akhtar, A. M., Krapitchev, A., Choudhury, R. P., Anthony, D. C., & Sibson, N. R. (2011) · The FASEB Journal · doi:10.1096/fj.11-183772 · Cited by 79
Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse
Macdonald, I. R., DeBay, D. R., Reid, G. A., O’Leary, T. P., Jollymore, C. T., Mawko, G., Burrell, S., Martin, E., Bowen, C. V., Brown, R. E., et al. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140505111354 · Cited by 79
Modeling Alzheimer's disease in transgenic mice: effect of age and of Presenilin1 on amyloid biochemistry and pathology in APP/London mice
Dewachter, I., Dorpe, J. V., Spittaels, K., Tesseur, I. C., den Haute, C. V., Moechars, D., & LEUVEN, F. V. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00149-2 · Cited by 78
Kinetics of Cerebral Amyloid Angiopathy Progression in a Transgenic Mouse Model of Alzheimer Disease
Robbins, E. M., Betensky, R. A., Domnitz, S. B., Purcell, S. M., Garcı́a-Alloza, M., Greenberg, C., Rebeck, G. W., Hyman, B. T., Greenberg, S. M., Frosch, M. P., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3854-05.2006 · Cited by 78
Aged Tg2576 mice are impaired on social memory and open field habituation tests
Deacon, R. M. J., Koroś, E., Bornemann, K. D., & Rawlins, J. N. P. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.042 · Cited by 78
Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer’s disease
Lai, A. Y., Dorr, A. E., Thomason, L. A. M., Koletar, M. M., Sled, J. G., Stefanovic, B., & McLaurin, J. (2015) · Brain · doi:10.1093/brain/awv023 · Cited by 77
Early and Progressive Impairment of Spinal Blood Flow—Glucose Metabolism Coupling in Motor Neuron Degeneration of ALS Model Mice
Miyazaki, K., Masamoto, K., Morimoto, N., Kurata, T., Mimoto, T., Obata, T., Kanno, I., & Abe, K. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.155 · Cited by 75
Vascular endothelial growth factor prevents G93A‐SOD1‐induced motor neuron degeneration
Lunn, J. S., Sakowski, S. A., Kim, B., Rosenberg, A. A., & Feldman, E. L. (2009) · Developmental Neurobiology · doi:10.1002/dneu.20747 · Cited by 74
Enhanced Adult Neurogenesis Increases Brain Stiffness: In Vivo Magnetic Resonance Elastography in a Mouse Model of Dopamine Depletion
Klein, C., Hain, E. G., Braun, J., Riek, K., Mueller, S. G., Steiner, B., & Sack, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092582 · Cited by 72
Analysis of motor function in 6-month-old male and female 3xTg-AD mice
Stover, K. R., Campbell, M. A., Winssen, C. M. V., & Brown, R. E. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.046 · Cited by 71
Early Alterations in Functional Connectivity and White Matter Structure in a Transgenic Mouse Model of Cerebral Amyloidosis
Grandjean, J., Schroeter, A., He, P., Tanadini, M., Keist, R., Krstic, D., Konietzko, U., Klohs, J., Nitsch, R. M., & Rudin, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4762-13.2014 · Cited by 70
Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease
Sawiak, S. J., Wood, N. I., Williams, G. B., Morton, A. J., & Carpenter, T. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.09.017 · Cited by 70
Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease
Wang, X., Sarkar, A., Cicchetti, F., Yu, M., Zhu, A., Jokivarsi, K. T., Saint‐Pierre, M., & Brownell, A. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.12.011 · Cited by 70
Environment-contact administration of rotenone: A new rodent model of Parkinson’s disease
Liu, Y., Sun, J., Song, L.-K., Li, J., Chu, S., Yuan, Y., & Chen, N. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.058 · Cited by 69
In Vivo Imaging Reveals Distinct Inflammatory Activity of CNS Microglia versus PNS Macrophages in a Mouse Model for ALS
Dibaj, P., Steffens, H., Zschüntzsch, J., Nadrigny, F., Schomburg, E. D., Kirchhoff, F., & Neusch, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017910 · Cited by 67
Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington’s disease
Lee, W., & Chang, C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.02.002 · Cited by 67
Multimodal Nanoprobes to Target Cerebrovascular Amyloid in Alzheimer’s Disease Brain
Jaruszewski, K. M., Curran, G. L., Swaminathan, S. K., Rosenberg, J. T., Grant, S. C., Ramakrishnan, S., Lowe, V. J., Poduslo, J. F., & Kandimalla, K. K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.075 · Cited by 64
Transgenic Mouse Models of Alzheimer’s Disease: Behavioral Testing and Considerations
Bryan, K. J., Lee, H., Perry, G. L., Smith, M. A., & Casadesús, G. (2009) · Europe PMC (PubMed Central) · Cited by 64
Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure
Gu, H., Robison, G., Hong, L., Barrea, R. A., Wei, X., Farlow, M. R., Pushkar, Y., Du, Y., & Zheng, W. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.002 · Cited by 64
Comparison of amyloid plaque contrast generated by T2‐weighted, T‐weighted, and susceptibility‐weighted imaging methods in transgenic mouse models of Alzheimer's disease
Chamberlain, R., Reyes, D. A., Curran, G. L., Marjańska, M., Wengenack, T. M., Poduslo, J. F., Garwood, M., & Jack, C. R. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21951 · Cited by 62
Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
Li, X., Chang, R., Liu, X., & Li, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s58470 · Cited by 62
Cortical atrophy and hypoperfusion in a transgenic mouse model of Alzheimer's disease
Hébert, F., Grand’Maison, M., Ho, M., Lerch, J. P., Hamel, É., & Bedell, B. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.022 · Cited by 62
Gene expression regulation of Bcl2, Bax and cytochrome-C by geraniol on chronic MPTP/probenecid induced C57BL/6 mice model of Parkinson’s disease
Rekha, K. R., & Selvakumar, G. P. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.04.010 · Cited by 62
Parkinsonism and Related Disorders
Slow, E., & Lang, A. E. (2019) · DeckerMed Transitional Year Weekly Curriculum™ · doi:10.2310/tywc.1178 · Cited by 62
Chronic Administration of Quinolinic Acid in the Rat Striatum Causes Spatial Learning Deficits in a Radial Arm Water Maze Task
Shear, D. A., Dong, J., Haik-Creguer, K. L., Bazzett, T. J., Albin, R. L., & Dunbar, G. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6767 · Cited by 61
Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1G93A G1H transgenic mouse model of amyotrophic lateral sclerosis
Zang, D. W., Yang, Q., Wang, H. X., Egan, G. F., Lopes, E. C., & Cheema, S. S. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03648.x · Cited by 60
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson’s disease
Baranyi, M., Porceddu, P. F., Gölöncsér, F., Kulcsár, S., Otrokocsi, L., Kittel, Á., Pinna, A., Frau, L., Huleatt, P., Khoo, M.-L., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0067-y · Cited by 60
PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of β-Amyloid Plaques
Martins, A. F., Morfin, J., Kubíčková, A., Kubíček, V., Buron, F., Suzenet, F., Salerno, M., Lazar, A. N., Duyckaerts, C. J., Arlicot, N., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400042w · Cited by 60
Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease
Andringa, G., Drukarch, B., Bol, J. G. J. M., de Bruin, K. M., Sörman, K., Habraken, J. B. A., & Booij, J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.03.034 · Cited by 59
In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient
NIESSEN, H., Angenstein, F., SANDER, K., Kunz, W. S., Teuchert, M., Ludolph, A. C., Heinze, H.-J., Scheich, H., & Vielhaber, S. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.04.007 · Cited by 57
Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10
SHARMA, S. K., Refaey, H. E., & Ebadi, M. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.11.019 · Cited by 56
In vivo NMR studies of regional cerebral energetics in MPTP model of P arkinson's disease: recovery of cerebral metabolism with acute levodopa treatment
Bagga, P., Chugani, A. N., Varadarajan, K. S., & Patel, A. B. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12407 · Cited by 56
Elevated arteriolar cerebral blood volume in prodromal Huntington's disease
Hua, J., Unschuld, P. G., Margolis, R. L., van Zijl, P. C. M., & Ross, C. A. (2013) · Movement Disorders · doi:10.1002/mds.25591 · Cited by 54
Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS
Barbeito, A. G., Palma, L. M., Vargas, M. R., Pehar, M., Mañáy, N., Beckman, J. S., Barbeito, L., & Cassina, P. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.007 · Cited by 54
Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage
Nessler, S., Boretius, S., Stadelmann, C., Bittner, A., Merkler, D., Hartung, H. ‐., Michaelis, T., Brück, W., Frahm, J., Sommer, N., et al. (2007) · Brain · doi:10.1093/brain/awm105 · Cited by 54
Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models
Nathoo, N., Yong, V. W., & Dunn, J. F. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.04.011 · Cited by 53
Cerebral Microvascular Rather than Parenchymal Amyloid-β Protein Pathology Promotes Early Cognitive Impairment in Transgenic Mice
Xu, W., Xu, F., Anderson, M. E., Kotarba, A. E., Davis, J., Robinson, J. K., & Nostrand, W. E. V. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130758 · Cited by 52
Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the R6/2 Mouse Model of HD
Rattray, I., Smith, E. J., Gale, R., Matsumoto, K., Bates, G. P., & Modo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060012 · Cited by 52
PET Imaging of Translocator Protein (18 kDa) in a Mouse Model of Alzheimer's Disease UsingN-(2,5-Dimethoxybenzyl)-2-18F-Fluoro-N-(2-Phenoxyphenyl)Acetamide
James, M. L., Belichenko, N. P., Nguyen, T. V., Andrews, L., Ding, Z., Liu, H., Bodapati, D., Arksey, N., Shen, B., Cheng, Z., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.141648 · Cited by 52
Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis
Tovar‐y‐Romo, L. B., Santa-Cruz, L. D., & Tapia, R. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-31 · Cited by 52
Progressive Loss of Motor Neuron Function in Wasted Mice: Effects of a Spontaneous Null Mutation in the Gene for the eEF1A2 Translation Factor
Newbery, H. J., Gillingwater, T. H., Dharmasaroja, P., Peters, J., Wharton, S. B., Thomson, D., Ribchester, R. R., & Abbott, C. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.4.295 · Cited by 51
Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model
Cheng, Y., Peng, Q., Hou, Z., Aggarwal, M., Zhang, J., Mori, S., Ross, C. A., & Duan, W. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.022 · Cited by 50
Intraspinal Injection of Human Umbilical Cord Blood-Derived Cells Is Neuroprotective in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
Knippenberg, S., Thau, N., Schwabe, K., Dengler, R., Schambach, A., Hass, R., & Petri, S. (2011) · Neurodegenerative Diseases · doi:10.1159/000331327 · Cited by 49
Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with 18F-DPA-714 and micro-PET/CT
Gargiulo, S., Anzilotti, S., Coda, A. R. D., Gramanzini, M., Greco, A., Panico, M., Vinciguerra, A., Zannetti, A., Vicidomini, C., Dollé, F., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3311-y · Cited by 48
Self-citation
Cerebellar lipid differences between R6/1 transgenic mice and humans with Huntington’s disease
Denny, C. A., Desplats, P., Thomas, E. A., & Seyfried, T. N. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06964.x · Cited by 48
Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model
Rönnbäck, A., Zhu, S., Dillner, K., Aoki, M., Lilius, L., Näslund, J., Winblad, B. G., & Graff, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.021 · Cited by 47
Mouse models in neurological disorders: Applications of non-invasive imaging
Waerzeggers, Y., Monfared, P., Viel, T., Winkeler, A., & Jacobs, A. H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.04.009 · Cited by 47
Gene and protein therapies utilizing VEGF for ALS
Keifer, O. P., O'Connor, D. M., & Boulis, N. M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.009 · Cited by 46
Quantitative [123I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease
Alvarez‐Fischer, D., Blessmann, G., Trosowski, C., Béhé, M. P., Schurrat, T., Hartmann, A., Behr, T. M., Oertel, W. H., Höglinger, G. U., & Höffken, H. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.05.056 · Cited by 46
A Longitudinal Study of Behavioral Deficits in an AβPP Transgenic Mouse Model of Alzheimer's Disease
Havas, D., Hutter‐Paier, B., Ubhi, K. K., Rockenstein, E. M., Crailsheim, K., Masliah, E., & Windisch, M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101866 · Cited by 45
Compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?
Kreiner, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00056 · Cited by 45
A 99m Tc-HMPAO single-photon emission computed tomography study of Lewy body disease
Varma, A. R., Talbot, P. R., Snowden, J. S., Lloyd, J. J., Testa, H. J., & Neary, D. (1997) · Journal of Neurology · doi:10.1007/s004150050101 · Cited by 45
Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by in vivo magnetic resonance angiography at 17.6T
Kara, F., van Dongen, E. S., Schliebs, R., van Buchem, M. A., de Groot, H. J. M., & Alia, A. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.055 · Cited by 44
PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: A comparison between [11C]CIC and [11C]MeDAS
Faria, D. D. P., de Vries, E. F. J., Sijbesma, J. W. A., Dierckx, R., Buchpiguel, C. A., & Copray, S. C. V. M. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.10.057 · Cited by 44
Alzheimer’s Disease and the Blood–Brain Barrier: Past, Present and Future
Bowman, G. L., & Quinn, J. F. (2008) · Aging Health · doi:10.2217/1745509x.4.1.47 · Cited by 43
Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging
Klohs, J., Politano, I. W., Deistung, A., Grandjean, J., Drewek, A., Dominietto, M., Keist, R., Schweser, F., Reichenbach, J. R., Nitsch, R. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066097 · Cited by 42
Optical imaging in an Alzheimer’s mouse model reveals amyloid-β-dependent vascular impairment
Lin, A. J., Liu, G., Castello, N. A., Yeh, J. J., Rahimian, R., Lee, G., Tsay, V., Durkin, A. J., Choi, B., LaFerla, F. M., et al. (2014) · Neurophotonics · doi:10.1117/1.nph.1.1.011005 · Cited by 41
The role of angiogenesis in the pathology of multiple sclerosis
Lengfeld, J. E., Cutforth, T., & Agalliu, D. (2014) · Vascular Cell · doi:10.1186/s13221-014-0023-6 · Cited by 41
Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis
Lynch, J. L., Gallus, N. J., Ericson, M. E., & Beitz, A. J. (2008) · Pain · doi:10.1016/j.pain.2007.07.007 · Cited by 41
Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the α5β1 integrin
Boroujerdi, A., Welser-Alves, J. V., & Milner, R. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.09.009 · Cited by 39
Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing–Remitting Experimental Autoimmune Encephalomyelitis
Mattner, F., Staykova, M. A., Berghofer, P., Wong, H. J., Fordham, S. A., Callaghan, P. D., Jackson, T. W., Pham, T. Q., Grégoire, M., Zahra, D., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.108894 · Cited by 39
The Bradykinin B1 Receptor Regulates Aβ Deposition and Neuroinflammation in Tg-SwDI Mice
Passos, G. F., Medeiros, R., Cheng, D., Vasilevko, V., LaFerla, F. M., & Cribbs, D. H. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.021 · Cited by 38
Mouse Models of Polyglutamine Diseases in Therapeutic Approaches: Review and Data Table. Part II
Switonski, P. M., Szlachcic, W. J., Gabka, A., Krzyżosiak, W. J., & Figiel, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8316-3 · Cited by 38
A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles
Southwell, A. L., Skotte, N. H., Villanueva, E. B., Østergaard, M. E., Gu, X., Kordasiewicz, H. B., Kay, C., Cheung, D., Xie, Y., Waltl, S., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx021 · Cited by 38
PET imaging studies show enhanced expression of mGluR5 and inflammatory response during progressive degeneration in ALS mouse model expressing SOD1-G93A gene
Brownell, A., Kuruppu, D., Kil, K.-E., Jokivarsi, K. T., Poutiainen, P., Zhu, A., & Maxwell, M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0439-9 · Cited by 37

Research works printed but not linked: 1

Dehghan, S., Mohajeri, M., & Javan, M. (2016). Animal models of multiple sclerosis. 5th Tehran IBRO School of Neuroscience, Chap. 1, pp. 3–16.

Sorted by citations

Electrochemical Biosensor for Point-of-Care Testing of Low-Abundance Biomarkers of Neurological Diseases
Huang, Z., Zhang, L., Dou, Y., Liu, X., Song, S., Jiang, H., & Fan, C. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c01278 · Cited by 41
Systematic metabolic analysis of potential target, therapeutic drug, diagnostic method and animal model applicability in three neurodegenerative diseases
Li, W., Li, G., Tong, X., Yang, P., Huang, J., Xu, L., & Dai, S. (2020) · Aging · doi:10.18632/aging.103253 · Cited by 30
Control of the temporal development of Alzheimer’s disease pathology by the MR1/MAIT cell axis
Wyatt-Johnson, S. K., Kersey, H. N., Codocedo, J. F., Newell, K. L., Landreth, G. E., Lamb, B. T., Oblak, A. L., & Brutkiewicz, R. R. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02761-6 · Cited by 22
Diffusion tensor imaging‐based studies at the group‐level applied to animal models of neurodegenerative diseases
Müller, H.-P., Roselli, F., Rasche, V., & Kassubek, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00734 · Cited by 12
Radiomics and Radiogenomics in Preclinical Imaging on Murine Models: A Narrative Review
Monti, S., Truppa, M. E., Albanese, S., & Mancini, M. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13081204 · Cited by 5
Self-citation

See all 16

Authors: Albanese, S., Greco, A., Auletta, L., & Mancini, M.
Affiliations: CEINGE Biotecnologie Avanzate Franco Salvatore (Italy) (IT)
Institute of Biostructure and Bioimaging (IT)
Corresponding author: Greco, Adelaide
ORCID: Albanese, Sandra
Greco, Adelaide
Auletta, Luigi
Mancini, Marcello
Venue: Brain Imaging and Behavior
Publisher: Springer Science and Business Media LLC
Published: 2017-10-26
Volume: 12
Issue: 4
Pages: 1160-1196
ISSN: 1931-7557 (ISSN-L)
1931-7565
DOI: 10.1007/s11682-017-9770-3
OpenAlex: W2766657139
Cited by: 16
References: 289
Citations by year: 2026: 1 · 2025: 3 · 2024: 4 · 2023: 3 · 2021: 1 · 2020: 3 · 2019: 1
FWCI: 0.11
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (unspecified)
Locations: Brain Imaging and Behavior (publishedVersion)
PubMed (publishedVersion)
Funders: Italian Ministry for Education, University and Research in the framework of PRIN (2010XE5L2R_004)
Topics: Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: neurodegenerative diseases, mouse model, small animal imaging, vascular pathology, behavioral tests, drug screening, in vivo imaging, contrast media, translational research
MeSH terms: Neurovascular Coupling, Animals, Disease Models, Animal, Neurodegenerative Diseases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mouse models of neurodegenerative disease: preclinical imaging and neurovascular component

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks